![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
SALT LAKE CITY, July 17, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced results from its nationwide Cancer...
SALT LAKE CITY and FREMONT, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq: MYGN), a leader in genetic testing and precision medicine, and Personalis, Inc. (Nasdaq:...
SALT LAKE CITY, July 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the United States Patent and...
SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has received the Great Place To...
SALT LAKE CITY, June 24, 2024 (GLOBE NEWSWIRE) -- A significant 40% of Americans report feeling ‘depressed and/or anxious’ around the election season according to the latest GeneSight® Mental...
SALT LAKE CITY, June 11, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a collaboration with GSK aimed at...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.54 | -1.46193278906 | 105.34 | 105.34 | 103.8 | 20 | 105.34 | DE |
4 | -0.52 | -0.498466257669 | 104.32 | 105.34 | 103.8 | 19 | 104.85684211 | DE |
12 | -4.24 | -3.92447241762 | 108.04 | 108.04 | 103.8 | 19 | 105.88 | DE |
26 | 1.3 | 1.26829268293 | 102.5 | 108.04 | 99.22 | 46 | 101.9298917 | DE |
52 | 9.91 | 10.5549046757 | 93.89 | 108.04 | 93.89 | 40 | 101.83835846 | DE |
156 | 9.91 | 10.5549046757 | 93.89 | 108.04 | 93.89 | 40 | 101.83835846 | DE |
260 | 9.91 | 10.5549046757 | 93.89 | 108.04 | 93.89 | 40 | 101.83835846 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions